The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved Altuvoct (efanesoctocog alfa) to be used to ...

Pfizer's strong Q4 2024 results showcase growth in cancer drugs and Vyndaqel sales. Learn why PFE stock is a top pick for ...

Sobi’s Sanofi-partnered efanesoctocog alfa has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA ...

Another rival is Sanofi’s long-acting FVIII replacement therapy Altuviiio (efanesoctocog alfa), which also offers once-weekly dosing. Haemophilia B is likely to be the greatest opportunity for ...

The FDA granted orphan designation to Sanofi (SNY) US Services’ rilzabrutinib as a treatment of autoimmune hemolytic anemia, according to a post to the agency’s website. Published first on ...

This month on pharmaphorum, we explore the history of French pharmaceutical company Sanofi, which was created through many partnerships and acquisitions over a period of 100 years. Sanofi is one ...

New York, USA, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Hemophilia Market Insights: Key Trends and Developments Across Different Types of Hemophilia | DelveInsight The hemophilia market is expected to ...

In January 2018, Sanofi and Alnylam Pharmaceuticals reorganized their RNAi therapeutics partnership to streamline and enhance the development and commercialization of select products aimed at ...

New York, USA, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Hemophilia Market Insights: Key Trends and Developments Across Different Types of Hemophilia | DelveInsight The hemophilia market is expected to ...